                         SEQUENCE LISTING

<110>  Yeda Research and Development Co. Ltd.
 
<120>  PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED 
       PATHOLOGIES

<130>  YEDA/0117 PCT

<150>  US61/664778
<151>  2012-06-27

<160>  23    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  1

His Thr Thr Trp Met Glu Trp Asp 
1               5               


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  2

Trp Asn His Thr Thr Trp Met Glu Trp Asp 
1               5                   10  


<210>  3
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  3

Ser Asn Lys Ser Leu Glu Gln Ile Trp Asn His Thr Thr Trp Met Glu 
1               5                   10                  15      


Trp Asp 
        


<210>  4
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  4

Glu Gln Ile Trp Asn His Thr Thr Trp Met Glu Trp Asp Arg Glu Ile 
1               5                   10                  15      


Asn Asn 
        


<210>  5
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ser

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  D-Asp

<400>  5

Ser Asn Lys Ser Leu Glu Gln Ile Trp Asn His Thr Thr Trp Met Glu 
1               5                   10                  15      


Trp Asp 
        


<210>  6
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  6

Leu Gln Ala Arg Ile Leu Ala Val Glu Arg Tyr Leu Lys Asp Gln Gln 
1               5                   10                  15      


Leu 
    


<210>  7
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  7

Thr Thr Ala Val Pro Trp Asn Ala Ser Trp Ser Asn Lys Ser Leu Glu 
1               5                   10                  15      


Gln Ile 
        


<210>  8
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  8

Trp Asn Ala Ser Trp Ser Asn Lys Ser Leu Glu Gln Ile Trp Asn His 
1               5                   10                  15      


Thr 
    


<210>  9
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  9

Ser Asn Lys Ser Leu Glu Gln Ile Gly Asn His Thr Thr Gly Met Glu 
1               5                   10                  15      


Gly Asp 
        


<210>  10
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  10

Ser Asn Lys Ser Leu Glu Gln Ile Trp Asn His Thr Thr Trp Met Gly 
1               5                   10                  15      


Trp Gly 
        


<210>  11
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Trp

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Asn

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-His

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Thr

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-Thr

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Trp

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Met

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  D-Trp

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-Asp

<400>  11

Trp Asn His Thr Thr Trp Met Glu Trp Asp 
1               5                   10  


<210>  12
<211>  37
<212>  PRT
<213>  Human immunodeficiency virus type 1

<400>  12

Thr Thr Ala Val Pro Trp Asn Ala Ser Trp Ser Asn Lys Ser Leu Glu 
1               5                   10                  15      


Gln Ile Trp Asn His Thr Thr Trp Met Glu Trp Asp Arg Glu Ile Asn 
            20                  25                  30          


Asn Tyr Thr Ser Leu 
        35          


<210>  13
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  13

Lys Leu Lys Leu Leu Lys Leu Leu Lys Leu Leu Lys Leu Leu Lys 
1               5                   10                  15  


<210>  14
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  14

Gly Leu Arg Ile Leu Leu Leu Lys Val 
1               5                   


<210>  15
<211>  21
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  15

Met Glu Val Gly Trp Tyr Arg Ser Pro Phe Ser Arg Val Val His Leu 
1               5                   10                  15      


Tyr Arg Asn Gly Lys 
            20      


<210>  16
<211>  34
<212>  PRT
<213>  Human immunodeficiency virus type 1

<400>  16

Thr Thr Ala Val Pro Trp Asn Ala Ser Trp Ser Asn Lys Ser Leu Glu 
1               5                   10                  15      


Gln Ile Trp Asn His Thr Thr Trp Met Glu Trp Asp Arg Glu Ile Asn 
            20                  25                  30          


Asn Tyr 
        


<210>  17
<211>  30
<212>  PRT
<213>  Human immunodeficiency virus type 2

<400>  17

Cys His Thr Thr Val Pro Trp Val Asn Asp Ser Leu Ala Pro Asp Trp 
1               5                   10                  15      


Asp Asn Met Thr Trp Gln Glu Trp Glu Lys Gln Val Arg Tyr 
            20                  25                  30  


<210>  18
<211>  30
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  18

His Thr Thr Val Pro Trp Pro Asn Ala Ser Leu Thr Pro Asp Trp Asn 
1               5                   10                  15      


Asn Asp Thr Trp Gln Glu Trp Glu Arg Lys Val Asp Phe Leu 
            20                  25                  30  


<210>  19
<211>  54
<212>  PRT
<213>  Feline immunodeficiency virus

<400>  19

Phe Cys Lys Ile Pro Leu Glu Leu Trp Thr Arg Tyr Asn Met Thr Ile 
1               5                   10                  15      


Asn Gln Thr Ile Trp Asn His Gly Asn Ile Thr Leu Gly Glu Trp Tyr 
            20                  25                  30          


Asn Gln Thr Lys Asp Leu Gln Gln Lys Phe Tyr Glu Ile Ile Met Asp 
        35                  40                  45              


Ile Glu Gln Asn Asn Val 
    50                  


<210>  20
<211>  24
<212>  PRT
<213>  Human T-cell lymphotropic virus type 1

<400>  20

Arg Val Leu Thr Gly Trp Gly Leu Asn Trp Asp Leu Gly Leu Ser Gln 
1               5                   10                  15      


Trp Ala Arg Glu Ala Leu Gln Thr 
            20                  


<210>  21
<211>  31
<212>  PRT
<213>  Moloney murine sarcoma virus

<400>  21

Thr Thr Ala Leu Met Ala Thr Gln Gln Phe Gln Gln Leu Gln Ala Ala 
1               5                   10                  15      


Val Gln Asp Asp Leu Arg Glu Val Glu Lys Ser Ile Ser Asn Leu 
            20                  25                  30      


<210>  22
<211>  45
<212>  PRT
<213>  Human T-cell lymphotropic virus type 2

<400>  22

Ala Val Pro Ile Ala Val Trp Leu Val Ser Ala Leu Ala Ala Gly Thr 
1               5                   10                  15      


Gly Ile Ala Gly Gly Val Thr Gly Ser Leu Ser Leu Ala Ser Ser Lys 
            20                  25                  30          


Ser Leu Leu Leu Glu Val Asp Lys Asp Ile Ser His Leu 
        35                  40                  45  


<210>  23
<211>  23
<212>  PRT
<213>  Feline leukemia virus

<400>  23

Asp Ser Gln Gln Gly Trp Phe Glu Gly Trp Phe Asn Lys Ser Pro Trp 
1               5                   10                  15      


Phe Thr Thr Leu Ile Ser Ser 
            20              


